iGMDRD66


Canonical SMILES: CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O

InChI: InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1

InChI Key: AOJJSUZBOXZQNB-TZSSRYMLSA-N

Loading, please wait...
Standard Name
CHEMBL
Pubchem CID
KEGG Drug ID
DRUGBANK ID
Drug Status
Drug targets (TTD)
Drug Type
Standard NameDoxorubicin
Pubchem CID31703
KEGG Drug IDD03899
DRUGBANK IDDB00997
Drug StatusAlone
Drug targets (TTD)DNC000163
Drug TypeSmall Molecule




Drug-model tissue-cancer distribution: Bubble Plot

UTERUtissue: UTERU cancer: UTERUS model num: 0UTERUStissue: UTERUS cancer: undefined model num: 1BLOOtissue: BLOO cancer: BLOOD model num: 0BLOODtissue: BLOOD cancer: undefined model num: 3undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 34BOWEtissue: BOWE cancer: BOWEL model num: 0BOWELtissue: BOWEL cancer: undefined model num: 1BREAStissue: BREAS cancer: BREAST model num: 0BREASTtissue: BREAST cancer: undefined model num: 1BREASTtissue: BREAST cancer: Breast Carcinoma model num: 4SKItissue: SKI cancer: SKIN model num: 0SKINtissue: SKIN cancer: undefined model num: 1SKINtissue: SKIN cancer: Cutaneous Melanoma (SKCM) model num: 1BONtissue: BON cancer: BONE model num: 0BONEtissue: BONE cancer: Acute Myeloid Leukemia (AML) model num: 2BLADDEtissue: BLADDE cancer: BLADDER model num: 0BLADDERtissue: BLADDER cancer: Bladder Cancer model num: 2BLADDERtissue: BLADDER cancer: Bladder Urothelial Carcinoma (BLCA) model num: 1OVARtissue: OVAR cancer: OVARY model num: 0OVARYtissue: OVARY cancer: Ovarian Cancer model num: 3LYMPtissue: LYMP cancer: LYMPH model num: 0LYMPHtissue: LYMPH cancer: Mantle Cell Lymphoma (MCL) model num: 2PANCREAtissue: PANCREA cancer: PANCREAS model num: 0PANCREAStissue: PANCREAS cancer: Pancreatic Adenocarcinoma (PAAD) model num: 1

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot


Loading, please wait...
Gene ID
Gene Name
Model Num.
7514 XPO1 1
5295 PIK3R1 1
83481 EPPK1 2
4170 MCL1 2
Showing 1 to 4 of 24 rows rows per page

Gene in drug-gene network: Network Plot

CCT 018159CCT 018159cytarabine.hydrochloridecytarabine.hydrochlorideGW-843682XGW-843682XCamptothecinCamptothecinZM-447439ZM-447439NSC141540NSC141540VX-680VX-680Epothilone.BEpothilone.BAZD7762AZD7762VincaleukoblastineVincaleukoblastineKAT2AKAT2ASMER3SMER3BIRB-796BIRB-796importazoleimportazolePL.DIPL.DIAM-580AM-580NilotinibNilotinibfingolimodfingolimodBelinostatBelinostaterastinerastinIrinotecanIrinotecanUGT1A1UGT1A1BMS-536924BMS-536924serdemetanserdemetanBML-259BML-259LY 2183240LY 2183240piperlonguminepiperlongumineBRD9876BRD9876zebularinezebularineCDK1CDK1PI-103PI-103BMS-754807BMS-754807Compound 44Compound 44ciclosporinciclosporintipifarnib-P2tipifarnib-P2itraconazoleitraconazoleCompound 110Compound 110Merck60Merck60SB225002SB225002bistramide Abistramide AnakiterpiosinnakiterpiosinYK.4.279YK.4.279(-)-gallocatechin-3-O-gallate(-)-gallocatechin-3-O-gallateBET inhibitorsBET inhibitorsCD437CD437kahalalide Fkahalalide FMYCMYCSMAD1SMAD1TAE-684TAE-684triacsin Ctriacsin CDC-45-A2DC-45-A2pluripotinpluripotinDMOGDMOGSRCSRCselumetinib in BRAF mutant tumorsselumetinib in BRAF mutant tumorspyrvinium pamoatepyrvinium pamoateOSI-906 (Linsitinib)OSI-906 (Linsitinib)BIX01294BIX01294CHIR-99021CHIR-99021PNU-74654PNU-74654isoevodiamineisoevodiamineCompound.7d.cisCompound.7d.cisABT737ABT737PK-11195PK-11195fumonisin.B1fumonisin.B1Tyrphostin AG 1478Tyrphostin AG 1478SirolimusSirolimusMCL1MCL1BI-2536BI-2536AZD-1775AZD-1775PaclitaxelPaclitaxelGSK-461364GSK-461364XL-880XL-880PF 184PF 184XPO1XPO1navitoclaxnavitoclaxcytochalasin.Bcytochalasin.Bparbendazoleparbendazoleleucascandrolide Aleucascandrolide ANsc 632839Nsc 632839nutlin 3nutlin 3Fqi1Fqi1TOP2ATOP2AMST-312MST-312salermidesalermideBRD63610BRD63610ML 210ML 210NSC95397NSC95397ML162ML162lovastatin acidlovastatin acidAACOCF3AACOCF3Vorinostat (SAHA)Vorinostat (SAHA)PAC-1PAC-1(1S,3R)-RSL3(1S,3R)-RSL3indisulamindisulamcurcumincurcuminLRP1BLRP1BSalinomycinSalinomycinGemcitabineGemcitabineZEB1ZEB1PX 12PX 12quinoclaminequinoclamineCIL55ACIL55ABRD6368BRD6368FedratinibFedratinibNPC26NPC26gossypolgossypolML214ML214TGFB1TGFB1ISX-9ISX-9avrainvillamideavrainvillamideBRD7137BRD7137PDGFRBPDGFRBUNC0638UNC0638BIBR-1532BIBR-1532Obatoclax.MesylateObatoclax.MesylateBleomycin (50 uM)Bleomycin (50 uM)BAY.61.3606BAY.61.3606PHA-665752PHA-665752ABT-263ABT-263PF4708671PF4708671NSG1NSG1Epigallocatechin-3-monogallateEpigallocatechin-3-monogallateERVK-19ERVK-19ParthenolideParthenolideubistatin Bubistatin BGMX1778GMX1778BRD4770BRD4770LexibulinLexibulinCHEK2CHEK2ZINC6718453ZINC6718453AZD6482.1AZD6482.1TGX221TGX221ZNF638ZNF638SNS-032SNS-032PHA-793887PHA-793887lapatinib in HER2-amplifiedlapatinib in HER2-amplifiedmyricetinmyricetinSR-II-138ASR-II-138Aruxolitinib (in SH2B3 deleted)ruxolitinib (in SH2B3 deleted)NSC48300NSC48300narciclasinenarciclasineLeptomycin BLeptomycin BtriptolidetriptolideEPPK1EPPK1neopeltolideneopeltolideEverolimusEverolimusmTOR inhibitorsmTOR inhibitorsCHM-1CHM-1TSC1TSC1NeratinibNeratinibPIK-75PIK-75ceruleninceruleninKDRKDRkinetin ribosidekinetin ribosideFK 866FK 866GW-405833GW-405833PD-0332991PD-0332991NSC23766NSC23766teniposideteniposideMDM2/MDMX inhibitorsMDM2/MDMX inhibitors4-methylfasudil4-methylfasudilRB1RB1CDK4/6 inhibitorsCDK4/6 inhibitorsMEK inhibitorsMEK inhibitorscetuximabcetuximabVER 155008VER 155008PanitumumabPanitumumabPLX-4720PLX-4720DabrafenibDabrafenibVemurafenibVemurafenibChloropentafluorobenzeneChloropentafluorobenzeneBinimetinib (MEK162)Binimetinib (MEK162)RefametinibRefametinibTrametinibTrametinibNRASNRASBX-795BX-795tivozanibtivozanibpevonedistatpevonedistatPIK3R1PIK3R1Nutlin-3aNutlin-3aMytomycin CMytomycin CY-39983Y-39983Cis-PlatinCis-PlatinTP53TP53Liposomal DoxorubicinLiposomal Doxorubicin

Models in Doxorubicin

Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
EXP(EPPK1) protein MCLP UTERUS undefined doxorubicin resistance in vitro
EXP(P27_pT198) protein MCLP BLOOD undefined Doxorubicin sensitivity in vitro
EXP(GCN5L2) protein MCLP BLOOD undefined Doxorubicin resistance in vitro
EXP(EIF2A_pS51) protein MCLP BLOOD undefined Doxorubicin resistance in vitro
EXP(CDK1) protein MCLP undefined PANCAN Doxorubicin resistance in vitro
EXP(CHK2_pT68) protein MCLP undefined PANCAN Doxorubicin sensitivity in vitro
EXP(CYCLINB1) protein MCLP undefined PANCAN Doxorubicin resistance in vitro
EXP(ERALPHA) protein MCLP undefined PANCAN Doxorubicin sensitivity in vitro
EXP(PR) protein MCLP undefined PANCAN Doxorubicin sensitivity in vitro
EXP(NDRG1_pT346) protein MCLP undefined PANCAN Doxorubicin sensitivity in vitro
Showing 1 to 10 of 57 rows rows per page

​​​​